Evidence of BBB disruption in AD has also been confirmed by the quantification of the accumulation of blood-derived neurotoxic proteins, such as fibrinogen, thrombin, albumin and IgG in the cortex and hippocampus of post-mortem tissues (Ryu and McLarnon, 2009). This evidence concerns the gene ALB and Alzheimer disease.